Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitchell S Cairo

Showing results (131-140 of 268) with videos related to

Pageof 27
Sort By:
Cancer Treatment Reviews|August 14, 2023
Expert consensus guidelines for the prophylaxis and management of tumor lysis syndrome in the United States: Results of a modified Delphi panelAnthony J Perissinotti, Michael R Bishop, Joseph Bubalo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2005
A phase I clinical, pharmacologic, and biologic study of thrombopoietin and granulocyte colony-stimulating factor in children receiving ifosfamide, carboplatin, and etoposide chemotherapy for recurrent or refractory solid tumors: a Children's Oncology Group experienceAnne L Angiolillo, Virginia Davenport, Mary Ann Bonilla, et al.
Molecular Therapy Oncolytics|October 26, 2019
Immunotherapeutic Challenges for Pediatric CancersBrian Hutzen, Mohammed Ghonime, Joel Lee, et al.
British Journal of Haematology|September 22, 2012
The immunophenotype of T-lymphoblastic lymphoma in children and adolescents: a Children's Oncology Group reportJay L Patel, Lynette M Smith, James Anderson, et al.
Cell Transplantation|February 12, 2013
Human cord blood-derived unrestricted somatic stem cells promote wound healing and have therapeutic potential for patients with recessive dystrophic epidermolysis bullosaYanling Liao, Munenari Itoh, Albert Yang, et al.
British Journal of Haematology|February 1, 2011
CD20 expression predicts survival in paediatric post-transplant lymphoproliferative disease (PTLD) following solid organ transplantationManuela A Orjuela, Bachir Alobeid, Xinhua Liu, et al.
Blood|November 15, 2012
Outcome and pathologic classification of children and adolescents with mediastinal large B-cell lymphoma treated with FAB/LMB96 mature B-NHL therapyMary Gerrard, Ian M Waxman, Richard Sposto, et al.
Molecular Therapy. Oncology|October 13, 2025
CXCL10-induced chemotaxis of <i>ex vivo</i>-expanded natural killer cells combined with NKTR-255 enhances anti-tumor efficacy in osteosarcomaShiori Eguchi, Wen Luo, Hongwen Zhu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 2, 2006
Characterization of cord blood natural killer and lymphokine activated killer lymphocytes following ex vivo cellular engineeringJanet Ayello, Carmella van de Ven, Weiwei Fortino, et al.
British Journal of Haematology|June 28, 2013
Rituximab pharmacokinetics in children and adolescents with de novo intermediate and advanced mature B-cell lymphoma/leukaemia: a Children's Oncology Group reportMatthew J Barth, Stanton Goldman, Lynette Smith, et al.
Pageof 27

Showing results (131-140 of 268) with videos related to

Sort By:
Pageof 27
Cancer Treatment Reviews|August 14, 2023
Expert consensus guidelines for the prophylaxis and management of tumor lysis syndrome in the United States: Results of a modified Delphi panelAnthony J Perissinotti, Michael R Bishop, Joseph Bubalo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2005
A phase I clinical, pharmacologic, and biologic study of thrombopoietin and granulocyte colony-stimulating factor in children receiving ifosfamide, carboplatin, and etoposide chemotherapy for recurrent or refractory solid tumors: a Children's Oncology Group experienceAnne L Angiolillo, Virginia Davenport, Mary Ann Bonilla, et al.
Molecular Therapy Oncolytics|October 26, 2019
Immunotherapeutic Challenges for Pediatric CancersBrian Hutzen, Mohammed Ghonime, Joel Lee, et al.
British Journal of Haematology|September 22, 2012
The immunophenotype of T-lymphoblastic lymphoma in children and adolescents: a Children's Oncology Group reportJay L Patel, Lynette M Smith, James Anderson, et al.
Cell Transplantation|February 12, 2013
Human cord blood-derived unrestricted somatic stem cells promote wound healing and have therapeutic potential for patients with recessive dystrophic epidermolysis bullosaYanling Liao, Munenari Itoh, Albert Yang, et al.
British Journal of Haematology|February 1, 2011
CD20 expression predicts survival in paediatric post-transplant lymphoproliferative disease (PTLD) following solid organ transplantationManuela A Orjuela, Bachir Alobeid, Xinhua Liu, et al.
Blood|November 15, 2012
Outcome and pathologic classification of children and adolescents with mediastinal large B-cell lymphoma treated with FAB/LMB96 mature B-NHL therapyMary Gerrard, Ian M Waxman, Richard Sposto, et al.
Molecular Therapy. Oncology|October 13, 2025
CXCL10-induced chemotaxis of <i>ex vivo</i>-expanded natural killer cells combined with NKTR-255 enhances anti-tumor efficacy in osteosarcomaShiori Eguchi, Wen Luo, Hongwen Zhu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 2, 2006
Characterization of cord blood natural killer and lymphokine activated killer lymphocytes following ex vivo cellular engineeringJanet Ayello, Carmella van de Ven, Weiwei Fortino, et al.
British Journal of Haematology|June 28, 2013
Rituximab pharmacokinetics in children and adolescents with de novo intermediate and advanced mature B-cell lymphoma/leukaemia: a Children's Oncology Group reportMatthew J Barth, Stanton Goldman, Lynette Smith, et al.
Pageof 27